.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Argus Health
Baxter
Daiichi Sankyo
Chubb
Fish and Richardson
Merck
US Department of Justice
Colorcon
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

Patents Expiring in April 2026

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Msd Intl GmbhZETIAezetimibeTABLET;ORAL021445-001Oct 25, 2002ABRXYesYes➤ Subscribe➤ SubscribeY
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-005Oct 7, 2016RXYesNo➤ Subscribe➤ SubscribeYMETHOD OF TREATING PULMONARY HYPERTENSION BY ORALLY ADMINISTERING A FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TREPROSTINIL
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-004Dec 20, 2013RXYesYes➤ Subscribe➤ SubscribeYMETHOD OF TREATING PULMONARY HYPERTENSION BY ORALLY ADMINISTERING A FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TREPROSTINIL
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-003Dec 20, 2013RXYesNo➤ Subscribe➤ SubscribeYMETHOD OF TREATING PULMONARY HYPERTENSION BY ORALLY ADMINISTERING A FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TREPROSTINIL
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-002Dec 20, 2013RXYesNo➤ Subscribe➤ SubscribeYMETHOD OF TREATING PULMONARY HYPERTENSION BY ORALLY ADMINISTERING A FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TREPROSTINIL
United TherapORENITRAMtreprostinil diolamineTABLET, EXTENDED RELEASE;ORAL203496-001Dec 20, 2013RXYesNo➤ Subscribe➤ SubscribeYMETHOD OF TREATING PULMONARY HYPERTENSION BY ORALLY ADMINISTERING A FORMULATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF TREPROSTINIL
Novartis Pharms CorpZYKADIAceritinibCAPSULE;ORAL205755-001Apr 29, 2014RXYesYes➤ Subscribe➤ SubscribeYY
Sage ProdsCHLORHEXIDINE GLUCONATEchlorhexidine gluconateCLOTH;TOPICAL021669-001Apr 25, 2005OTCYesYes➤ Subscribe➤ SubscribeY
Keryx BiopharmsAURYXIAferric citrateTABLET;ORAL205874-001Sep 5, 2014RXYesYes➤ Subscribe➤ SubscribeCONTROL OF SERUM PHOSPHOROUS LEVELS
Sunovion Pharms IncAPTIOMeslicarbazepine acetateTABLET;ORAL022416-004Nov 8, 2013RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
McKinsey
Colorcon
Harvard Business School
Mallinckrodt
QuintilesIMS
Julphar
Merck
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot